Fisher was the principle investigator on a recently completed quantitative study that resulted in a paper published in the journal AIDS and Behavior titled “Patient-Provider Communication Barriers and Facilitators to HIV and STI Preventive Services for Adolescent MSM.” In the study, Fisher found that young males who have sex with males were reticent to discuss sex with their doctors. But when doctors initiated the conversation, they were more forthcoming with vital information that could affect their health.

The nationwide study was conducted anonymously via a  questionnaire linked to from a trusted website frequented by gay teens. It surveyed 198 adolescent gay males. Several participants said they completed the survey because they wanted to help their community.

“This is the first study to ask kids about their attitudes on getting sexual health care,” said Fisher, who directs Fordham’s Center for Ethics Education. “Pediatricians and general practitioners are the gateway of youth experiences with health care, but [these patients]only go once a year, so this is an ideal time to ask [about their sexual activity].”

Fisher said there are several studies that have found that most doctors are not trained to ask questions relevant to sexual minorities, and many doctors assume the youth they treat are straight. Furthermore, the language of sexuality has evolved for young people.

“The other issue is that doctors should not use terms like ‘gay,’ or ‘LGBT,’ because for many young people the terminology is in flux,” said Fisher. “Youth no longer identify with these traditional behaviors; the question should be ‘Who are you attracted to sexually?’”

But most importantly, Fisher said, the conversation needs to be initiated by the doctors, even though doctors often have the “misperception that the kid would be uncomfortable.”

“Physicians need to be well versed in safety advice and should be able to communicate to all,” she said. “The kids don’t bring it up because they think the doctor will be prejudiced.”

Another concern among the young men was that the doctors might tell their parents, but Fisher said most states allow doctors to provide information to teens on sexual health, including HIV prevention, without parental consent. Some states, like New York, even allow doctors to prescribe PrEP, the pill that protects against HIV, to minors without getting parents involved.

“The grey area is if the child is having sex with an adult that might be considered sexual abuse and that needs to be reported,” said Fisher.

But such cases only reinforce the need for doctors need to be proactive in their conversations with youth, she said. Even if the relationship is legal and consensual, some youth lack assertiveness skills to demand a condom from an older or aggressive peer partner, she said.

“They need advice specific to males having sex with males,” said Fisher. “Giving gay males advice on sex with females is useless, but when they’re aware of those specifics they’ll be safer and healthier.”

Four years later, he’s back in the news, as he revealed he is HIV positive in a TODAY interview with Matt Lauer.

“It’s a hard three letters to absorb. It’s a turning point in one’s life,” the 50-year-old actor said to Lauer.

Human immunodeficiency virus, or HIV, is living inside the bodies of an estimated 35 million people worldwide. In the United States, 1.2 million people are living with HIV and the U.S. fails to prevent about another 50,000 infections every year. (source)

What does this high profile celebrity having HIV mean for the stigma often associated with the virus, or how the public is educated on the disease?

Fordham’s Celia Fisher, PhD, the director of both Fordham’s Center for Ethics Education and the HIV and Drug Abuse Prevention Research Ethics Training Institute, said a lot has changed since 1991, when NBA great Magic Johnson announced he was HIV positive.

“For those in countries where medication is widely available becoming HIV positive has become a chronic disease, rather than a death sentence on a path towards AIDS,” she said. “The risk of becoming infected has also been reduced through HIV prevention medications such as PrEP (Pre-Exposure Prophylaxis) that can prevent the acquisition of HIV, as well as evidence that taking certain HIV medications can lessen the risk of further transmission. There is also growing interest in using emerging technologies for HIV prevention, such as mobile health text reminders to take medication and the use of social media to increase HIV health literacy.”

Despite these medical gains, Fisher said, sexual and gender minority youth in the United States, and women in countries with extreme gender inequities and other marginalized populations, do not have access to these treatments.

“These inequities raise ethical challenges for public health policy makers, health providers, and medical and social behavioral researchers,” Fisher said. “The Fordham University HIV and Drug Abuse Prevention Research Ethics Training Institute is dedicated to training researchers how to uncover and address the causes of these inequities to create an AIDS-free world.”

To learn more about the hard data generated by the HIV and Drug Abuse Prevention Research Ethics Training Institute at Fordham—the only one of its kind, read this piece from last November.

For more information on HIV, see this article by Fordham alumnus, Mathew Rodriguez (FCLC ’11), in Mic.

The award is given annually to one APA member psychologist that is no more than ten years post doctoral degree, who has made a distinguished contribution to neuropsychology in research, scholarship, and clinical work.

Rivera Mindt is co-investigator of a study funded by the National Institute of Mental Health (NIMH) to gauge the cognitive functions in HIV-positive Latinos in New York who are on anti-retroviral therapies. The $1 million study will help identify cognitive and sociocultural barriers that may interfere with the ability of the cohort to adhere to their medication regimens.

As an award recipient, Rivera Mindt has been invited to present her research at the 119th Annual APA convention, to be held in Washington D.C. on Aug. 4 to 7.

Rivera Mindt teaches in the graduate program in clinical psychology and at the Mount Sinai School of Medicine. She has been a member of the Fordham faculty since 2002.

This is Rivera Mindt’s second national award; last October she received the 2010 Early Career Service Award from the National Academy of Neuropsychology. That award was given to her for her professional service, her service to the community, and her outstanding teaching/mentoring of her students.

Monica Rivera-Mindt, Ph.D., an associate professor of psychology, is doing just that as she works on a five-year study conducted at the Mount Sinai School of Medicine and funded by the National Institute of Mental Health.

The grant, which was awarded in 2007, involves recruiting 150 volunteers to take part in a pilot study of an intervention that is culturally tailored specifically toward Latinos. Rivera-Mindt said they’ve successfully recruited 110 volunteers, and hopes to hit the goal by February.

“Any time you engage in research with people, there are always bumps and surprises along the way, and my study is no exception in that regard,” she said. Recruitment was slow initially, and I had this desire to get involved in the community, but I didn’t know exactly how to approach the community in a meaningful way.”

Part of the challenge, she said, has been earning the trust of the community, so as to understand the needs of a disenfranchised population. Working with groups like Harlem Community Academic Partnership, the Manhattan HIV Care Network has helped.

“It’s not only about how my research can help them, but also how their perspective can inform my research. Because of their input, my research has evolved, and questions are emerging in ways that I didn’t expect and could not have known had I not been involved in the community,” she said.

“It turns out that broader social issues are also rally important to medication adherence in a way that I hadn’t thought about things like housing, and child care in order to go to the pharmacy or to see the doctor in order to get your medication.”

“Part of the population that I’m working with is somewhat transient, and sometimes they’re living with family or with friends, wherever, and they can’t disclose their HIV status, for issues of safety and other things, or being ostracized. So they hide their medications; they might not be able to take them into where they’re living.”

Rivera-Mindt is also working on a grant from the National Institute on Drug Abuse with a team at Albert Einstein College of Medicine examining the neurocognitive effects of bupenorphine (an opioid addiction therapy) among HIV-positive and HIV-negative opioid dependent adults.

Rivera-Mindt’s work has not gone unnoticed. When it meets for its annual conference in Vancouver on Oct. 13, The National Academy of Neuropsychology will present her with its 2010 Early Career Service Award, for her service to the profession, service to the community, and teaching, including supervision and mentoring. It’s the first national award she’s won for her work, and one she’s extremely grateful for.

“My research, teaching and supervision are all inter-connected. For me, the ultimate goal is to improve services and outcomes in terms of neuro-psychological functioning for all kinds of people, but especially for ethnically diverse, disenfranchised populations who tend to be underrepresented or under served,” she said. “So I feel this is part of that greater mission for me.”